Introduction
A role for calcium dysregulation in Alzheimer's disease (AD) was first postulated 20 years ago (Khachaturian, 1987) , and subsequent experimental studies have identified two principle means by which it impacts or is impacted by the disease. Altered neuronal calcium homeostasis may affect the metabolism and production of the pathological proteins associated with the disease-amyloid-beta peptide (Ab) and the microtubule-associated protein tau. Conversely, events downstream from the accumulation of these pathological proteins may further exacerbate calcium dysregulation, causing synaptic dysfunction and neurodegeneration-the neurobiological substrates underlying the cognitive decline.
Following this hypothesis, the involvement of calcium in AD was further substantiated with the recognition that clinical mutations in the presenilin (PS1/2) genes associated with familial AD (FAD) profoundly affect calcium release from the endoplasmic reticulum (ER) stores as well as calcium entry through storeoperated channels (LaFerla, 2002) . Although direct evidence for calcium disruption in the brains of AD patients has so far been technically challenging to obtain, circumstantial evidence from postmortem brains has been reported, such as increases in levels of calcium-dependent proteases (reviewed in Green et al., 2007) .
Researchers have traditionally turned to animal models of disease to explore human disorders in a living system in which invasive techniques could give answers to otherwise intractable questions, such as calcium dynamics in a living human neuron. However, the involvement of calcium in Ab-producing transgenic mouse models has been largely confounded by the use of FAD-associated presenilin mutations that, by themselves, perturb neuronal calcium dynamics, and surprisingly, calcium homeostasis has not yet been extensively studied in amyloid precursor protein (APP)-overexpressing mice without presenilin mutations. Twenty years since the first hypothesis paper, a number of recent seminal papers show evidence for (1) a role for calcium dysregulation in the initiation of the disease, (2) the downstream involvement of calcium in Ab-induced synaptic dysfunction, and (3) novel mechanisms linking presenilins and FAD-linked mutations to perturbed calcium homeostasis.
Calcium Regulation of Ab Production and Linkage to AD
Rare mutations in the APP and PS1/PS2 genes cause FAD by affecting the accumulation of the Ab peptide. Ninety-nine percent of AD cases are sporadic (SAD), with advancing age being a prerequisite for disease development. Like FAD, SAD is thought to be caused by the accumulation of the Ab peptide that occurs as a consequence of poorly understood complex genomic, proteomic, lipidomic, and environmental interactions. For many years, it has been known that changes in calcium levels and dynamics alter the metabolism and production of Ab (reviewed in Green et al., 2007) , implicating calcium dysfunction as a possible causative factor in SAD.
By screening genes located in known AD linkage regions, Philippe Marambaud and colleagues discovered a novel calcium-conducting channel, with polymorphisms associated with increased risk for the development of SAD (Dreses-Werringloer et al., 2008) . The association of these polymorphisms with SAD will require replication, but builds on a number of studies showing how altering calcium homeostasis affects Ab production. This calcium channel was found to be a conserved three-transmembrane domain containing glycoprotein, which they called calcium homeostasis modulator 1 (CALHM1). Expression of CALHM1 was found in all brain regions and cells of neuronal lineage. CALHM1 localized predominantly to the ER but also exists at the plasma membrane, where it forms a novel calcium influx route to the cytosol, which is unaffected by specific blockers of store-operated calcium influx or voltage-gated calcium channels but inhibited by nonspecific cation channel blockers such as colbalt (Figure 1 ). CALHM1 appears to exist as multimeric complexes, forming a functional ion channel, and has structural similarities with the NMDA receptor within the ion selectivity region. Critically, calcium influx through CALHM1 decreases Ab production and is accompanied by increases in sAPPa. The mechanism underling this effect is not elucidated but presumably involves a calcium-dependent effect on an a-secretase-these are enzymes that are known to cleave APP 83 amino acids from the carboxy terminus and thereby prevent Ab formation. Conversely, increases in Ab occur after siRNA knockdown of endogenous CALHM1 in cells when combined with calcium influx. Notably, the authors identified a polymorphism in the CALHM1 gene (rs2986017) causing a substitution of P86L, which decreases calcium permeability and also increases Ab production. If replicated, this finding provides direct genetic evidence of a calcium-conducting channel impacting the development of AD and shows that calcium influx pathways can affect APP processing to modulate the production of Ab.
The question of how calcium influx through CALHM1 affects APP processing has not been addressed. The authors link the P86L variant to SAD and also to impaired calcium permeability. Is this calcium route novel on its effects on APP or does calcium influx through any channel lead to similar effects on APP? Is it the level of calcium within the cytosol that is important, or is it more spatially regulated with regard to APP processing? The calcium influx pathway associated with the P86L polymorphism in CALHM1 decreases cytosolic calcium entry and is associated with higher Ab levels. Curiously, this observation is contradictory to the vast majority of studies published on cytosolic calcium entry and Ab production, which indicate that increasing calcium influx into the cytosol, either from the extracellular media or from ER stores, increases Ab production (Green et al., 2007) . Given the inconsistency with previous data, calcium entry through CALHM1 may represent a tightly controlled influx pathway with novel spatial links to APP processing, which other cytosolic calcium influx pathways do not seem to mimic.
The other unexplored possibility is that the effects of CALHM1 and the P86L variant exact their effects on Ab processing via their spatial location in the ER rather than the smaller pool found on the plasma membrane, given that the vast majority of CALHM1 was localized to the ER. It is unknown whether CALHM1 forms a functional cation-conducting pore within the ER, which could facilitate calcium influx or efflux from the stores. Future experiments should determine whether expression of CALHM1 affects ER calcium homeostasis and store levels. As the channel appears to be constitutively open (as membrane depolarization was not required for calcium influx), it may exist as a potential leak channel at the ER, which would increase cytosolic calcium and would be diminished by the P86L variant. This finding would then be in agreement with previous studies showing how ER calcium regulation modulates Ab production.
Calcium Dysregulation by Ab Accumulation
The question remains as to whether disturbances in calcium homeostasis mediate any of the downstream events, which lead from the aberrant production and accumulation of Ab to cognitive decline and neurodegeneration. It is vital to not only examine global calcium dynamics within neurons in pathologically affected areas, but also at discrete areas of neurons, such as the dendritic spines, which contain many of the postsynaptic synapses. This approach has been taken by Brian Bacskai and colleagues, who utilized an adeno-associated virus expressing the YC3.6 ratiometric calcium indicator (Kuchibhotla et al., Cytosolic calcium levels are kept low (100 nM) relative to the extracellular space and the intracellular stores by the presence of calcium-binding buffering proteins (e.g., calbindin), via the extrusion of cytosolic calcium across the plasma membrane through calcium ATPase pumps and exchangers, and also due to sequestration into intracellular stores such as the ER. Calcium influx into the cytosol is a tightly control process, both temporally and spatially, and occurs across the plasma membrane via store-operated calcium channels, voltage-gated calcium channels, the newly identified CALHM1, or from internal stores. The ER is the largest intracellular store, maintaining a high calcium concentration (100-500 mM) via the pumping of cytosolic calcium by SERCA. Calcium release from the ER into the cytosol occurs via two types of calcium channels: IP 3 Rs and RyRs. IP 3 R-mediated release is regulated at the plasma membrane by ligand binding to specific G protein-coupled receptors that induce phospholipase C to cleave phosphatidylinositol-4,5-bisphosphate into diacylglycerol and IP 3 , which then binds to the IP 3 R in the ER membrane. Dendritic spines also contain ER calcium stores, and regulation of ER calcium is set by the actions of SERCA, IP 3 Rs, and RyRs. Calcium influx across the plasma membrane occurs due to depolarization, through VGCCs and glutamate receptors such as the NMDA receptor and the metabotropic glutamate receptor. Presenilins are located within the ER membrane but are also found at the plasma membrane and other subcellular locations, and both wild-type and FAD-associated mutants increase IP 3 R-mediated calcium release, as well as modulate calcium regulation through both the RyR and SERCA. Mutant presenilins also impair endogenous calcium leak from the ER, resulting in increased store content, while CALHM1 is located mainly in the ER and appears to possess properties associated with a passive leak channel. APP is processed by either a-secretase, precluding Ab generation, or by b-secretase leading to Ab generation, after subsequent cleavage by the g-secreatse complex. Calcium influx through CALHM1 promotes the a-secretase pathway and reduces Ab generation. Conversely, increased calcium entry into the cytosol from the ER is associated with increased production of Ab.
Neuron 59, The study identified that plaque-containing transgenic mice had significantly elevated numbers of neurites (ten times more) with overloaded cytosolic calcium compared to age-matched nontransgenic controls, although these overloaded neurites represented only a small fraction of the total. This effect was independent of any FAD-linked presenilin mutations present but was positively correlated with the distance from Ab plaques. The source of the calcium overload was refined further by comparing the calcium load in the dendritic spine compartment with its immediate adjacent dendrite. Spines function as discrete compartments that can regulate the duration and spread of postsynaptic calcium transients due to glutamatergic neurotransmission. The induction of synaptic plasticity is dependent upon large rises in postsynaptic calcium levels. By acting as a discrete compartment, such rapid rises are possible and not translated through to the adjacent dendrite-calcium entering the spine is rapidly buffered and the remaining calcium quickly extruded with little time for remaining calcium ions to diffuse into the dendrite. Under physiological conditions, calcium levels in dendritic spines are regulated distinctly from those in the nearby dendrite, thereby allowing for independent calcium regulation. In areas close to plaques, a large proportion of spines had elevated basal calcium levels and had a strong correlation between the adjacent dendrite calcium levels. This finding suggests that the local compartmentalization of the spines with regard to calcium homeostasis has been lost and that spine calcium leaks out into the dendrite, preventing spine/dendrite independent calcium signaling.
The resting calcium concentration in these overloaded spines affected neurite morphology, with higher basal levels being associated with abnormal beaded morphology. These changes in morphology were prevented by inhibiting the calcium/calmodulin-dependent protein phosphatase 2B (calcineurin). Furthermore, spine motility is highly regulated by calcium levels, as many of the proteins involved in F-actin remodeling are calcium dependent (i.e., gelsolin), with increased calcium being associated with decreased motility and F-actin loss, which can be prevented with calcineurin antagonists (Oertner and Matus, 2005) . These results highlight for the first time that proximity to Ab plaques induces calcium dysregulation, and in discrete subcellular compartments, which are relevant to learning and memory, LTP, and synaptic loss. This seminal study provides data linking AD pathology and calcium dysregulation with subsequent morphological changes and opens the door to a number of compelling future studies. For example, it has been shown in many APP transgenic animals that both behavioral deficits and LTP deficits occur prior to extensive plaque deposition, albeit at ages when elevated Ab and oligomeric Ab levels are measured. Does this same neurite calcium overloading lead to the LTP and behavioral deficits in these younger animals? In the current study, the authors found no elevated neurite calcium in young APP/PS1 mice but did not examine this issue in Tg2576 mice at ages before plaques but coincident with cognitive deficits.
The source of elevated basal cytosolic calcium in neurites in close proximity to Ab plaques was unexplored by the authors.
Basal calcium levels are tightly regulated by a number of calcium pumps and binding proteins, which sequester free cytosolic calcium so that it cannot affect local enzymes and signaling cascades. Calcium enters the cytosol from the extracellular space through calcium-conducting voltage-dependent ion channels, such as voltage-gated calcium channels and glutamate receptors such as AMPA and NMDA receptors and also through store-operated calcium-entry channels, which are activated through ER calcium-depletion signaling pathways. Calcium can also enter the cytosol from intracellular stores such as the ER, via IP 3 and ryanodine receptors, as well as the mitochondria. Conversely, cytosolic calcium is reduced via the presence of calcium-binding proteins, such as calbindin, which act as buffers, and also through the extrusion of calcium either into intracellular stores, such as the ER via the sarco-endoplasmic reticulum ATPase (SERCA), or out across the plasma membrane via plasmalemmal calcium pumps and exchangers (Figure 1) . What is the source of the elevated basal cytosolic calcium proximal to the Ab plaques? Future studies will narrow this down, but circumstantial evidence points us to a number of possibilities. The first is the NMDA receptor-Ab oligomers bind to the NMDA receptor and induce calcium influx (De Felice et al., 2007) , whereas Ab-induced LTP deficits are dependent upon the NMDA receptor (Chen et al., 2002) . Influx through the NMDA receptor also leads to further calcium release into the cytosol from internal stores within the spine (Emptage et al., 1999) , which forms the major component of spine calcium transients. Notably, the NMDA partial antagonist memantine shows beneficial effects in moderate to severe AD patients. Second, there is an age-related decrease in the calcium-buffering protein calbindin, which is also decreased in APP transgenic mouse models (Palop et al., 2003) . Calbindin knockout mice have increased dendritic spine basal calcium (Chard et al., 1993) and develop abnormal spine morphologies (Vecellio et al., 2000) . Finally, Ab oligomers induce calcium influx across the plasma membrane through novel pores leading to increased cytosolic calcium (Demuro et al., 2005) .
Presenilins and Calcium Homeostasis
Fueling the fire for a role of calcium in the pathogenesis of AD, FAD-associated mutations in the presenilins were also found to enhance IP 3 -mediated calcium release from the ER stores, as well as perturb calcium entry through store-operated channels (LaFerla, 2002) . The presenilins were identified in 1995 as multi-membrane-spanning proteins, which predominantly localized to the ER, and were postulated to form a novel ion channel. Their involvement in the pathogenesis of AD was cemented with the discovery that the presenilins formed the catalytic core of the g-secretase complex, which liberates Ab from the membrane stub C99. These FAD mutations were found to shift the length of the Ab to a more predominantly 42 amino acid long version, which aggregates more readily. However, the role of these calcium perturbations in the disease progression have been hotly debated, as (1) such calcium-disturbing presenilin-dependent effects do not occur in SAD and (2) the increased length of Ab caused by presenilin mutations is sufficient to explain why these mutations lead to FAD, as some mutations in APP have also been identified that cause a similar shift in the length of Ab produced (i.e., the London mutation) and are also associated with FAD.
As such, there are two possibilities-first, the effects of presenilin mutations on cellular calcium play no role in FAD progression, or second, that while FAD presenilin mutations elongate Ab and give rise to FAD the perturbations in calcium caused by the same mutation further exacerbate the disease phenotype and/or progression.
Whether or not FAD presenilin mutations perturbing calcium homeostasis play a role in disease progression, the effects of these mutations on calcium are striking and the subject of some debate. Uniformly, these presenilin mutations have been shown to enhance IP 3 -mediated calcium release from the ER stores (LaFerla, 2002) , and several hypotheses have been put forward to explain this effect. Given that FAD presenilin mutations enhance calcium release from the ER via the IP 3 receptor (Leissring et al., 1999) , the ryanodine receptor via caffeine (Smith et al., 2005) , and through endogenous calcium leak channels (Tu et al., 2006) , it was thought that these results could all be explained by an increase in ER calcium load. These results have been shown via overexpression in Xenopus oocytes (Leissring et al., 1999) , mammalian cell lines (Smith et al., 2002) , primary neuronal cultures (Smith et al., 2005) , and slice imaging from knockin mice (Stutzmann et al., 2007) . However, the same FAD-linked mutations have also shown a reduction in ER calcium load and ER release with SERCA inhibition (Zatti et al., 2006) , including results from human fibroblast and rat neuronal cultures; thus, it is unclear whether all mutations increase ER calcium or not. Regardless of ER calcium load, all researchers have consistently measured increased IP 3 -mediated calcium release with FAD mutations.
Foskett and colleagues employed direct IP 3 channel recordings via single-channel patch-clamp electrophysiology of the ER membrane, expressing presenilin or FAD-linked mutants (Cheung et al., 2008) . Overexpression of mutant presenilin 1 or 2 directly increased IP 3 channel activity in the presence of both suboptimal and saturated [IP 3 ] by prolonging the channel open time. In comparison, wild-type presenilin overexpression had only modest effects on IP 3 channel activity. Increased IP 3 receptor gating accounted for the enhanced IP 3 receptor-mediated calcium release in the presence of presenilin FAD mutants, as direct measurement of ER calcium stores showed either no change or a modest reduction compared to control cells. Presenilin mutants appear to modulate the IP 3 receptors directly, as they were found to physically interact and are known to colocalize to the ER membrane, although it should be noted that this interaction was observed with overexpression of hydrophobic ER proteins, which could give false-positive results. These results show a novel interaction between presenilin FAD mutants and the IP 3 receptor, which are able to modulate gating activity and affect global calcium dynamics, and are consistent with recordings from mutant presenilin knockin mice fibroblasts that show increased sensitivity to IP 3 receptor agonists (Leissring et al., 2000) .
Such results add to a growing body of evidence that presenilin FAD mutations affect ER calcium dynamics on multiple levels. In addition to interacting with the IP 3 receptor, presenilin have been shown to interact with the ryanodine receptor, via its N terminus, and to increase the open channel probability and mean current (Rybalchenko et al., 2008 ), similar to that described with the IP 3 receptor. Increased calcium release via the ryanodine receptor has been described in a number of systems, including slice recordings from FAD presenilin mutant knockin mice (Stutzmann et al., 2007) and primary neuronal cultures (Smith et al., 2005) and may be due to increased ryanodine receptor expression and activity.
In addition to these ''gain-of-function'' interactions with native ER calcium receptors, FAD-linked presenilin mutations have also been shown to have a ''loss-of-function'' effect on ER calcium dynamics by reducing endogenous calcium leak from the ER (Tu et al., 2006) . Such an effect would lead to increased ER calcium load and overfilled ER stores and could explain the increases in ER calcium release observed by many researchers through a variety of routes, including IP 3 -mediated calcium release. It was suggested that presenilins themselves form a calcium leak channel in the ER, which is disrupted by FAD-linked mutations. However, in the study by Foskett and colleagues, no current through ER membrane was measured by patch clamp, despite overexpression of wild-type or FAD-linked presenilin mutants, in the absence of IP 3 , strongly arguing against presenilin forming calcium leak channels (Cheung et al., 2008) .
Clearly, FAD linked mutations in presenilins impact calcium on multiple levels, and it is not clear which one lies upstream or why different groups see opposing results with ER calcium load and release with the same presenilin mutations. However, given these profound effects that mutant presenilins have on cellular calcium homeostasis, it is feasible to postulate that endogenous presenilins play an integral role in calcium homeostasis, affecting the normal physiological cell biology. Presenilin knockout cells also display markedly perturbed calcium stores, typically reduced ER calcium stores, suggesting that the absence of presenilin has devastating effects on calcium regulation (Green et al., 2008) . The physiological role that presenilins play in calcium regulation may prove to be more important than understanding how FAD-linked mutations affect calcium dynamics, but are likely related. Elucidating whether endogenous presenilin affects the gating of the IP 3 or ryanodine receptor is crucial and can be done without the disadvantages of using an overexpression system, which could produce results that do not occur in normal cellular physiology or even pathophysiology.
We recently demonstrated that cells lacking both presenilins exhibit a phenotype similar to SERCA knockdown and that endogenous presenilins interact with SERCA (Green et al., 2008) . Overexpression of wild-type presenilins also accelerates the sequestration of cytosolic calcium, an effect that can be blocked by pharmacological inhibition of SERCA, suggesting that presenilins modulate SERCA function, and that SERCA pumping is impaired in the absence of both presenilins. Taken together, presenilins appear to interact and modulate calcium influx into the ER via SERCA, and calcium extrusion from the ER via interactions with the ryanodine and IP 3 receptors as well as through endogenous leak channels, and further experiments will be required to show which interactions are mediated in an endogenous role versus ones influenced by FAD mutant presenilins. Given the complex intricacies associated with calcium dynamics, it is likely that affecting any one of these calcium routes will have consequences for the others. In addition, it needs to be elucidated whether the effects of presenilin and presenilin mutants on calcium homeostasis are dependent on the g-secretase or whether these effects are independent and perhaps rely on uncleaved presenilin prior to its recruitment into the g-secretase complex. It is curious that all mutations that affect calcium homeostasis also alter g-secretase activity, whereas other presenilin mutations not associated with FAD do not (Nelson et al., 2007) , yet removal of the protease function of presenilins does not remove their effects on calcium (Tu et al., 2006) .
Foskett and colleagues showed that modulation of the IP 3 receptor could influence the production of Ab, with IP 3 receptor knockout resulting in marked reduction in Ab production (Cheung et al., 2008) . We have shown a similar result with knockdown of SERCA, also resulting in reduced Ab production, whereas overexpression of SERCA increases production (Green et al., 2008) . Given that SERCA pumps calcium into the ER and the IP 3 receptor releases calcium from the ER, it may be that it is increased ER calcium release that leads to increased Ab-SERCA activity will regulate ER release by setting the calcium gradient across the ER membrane. Furthermore, calcium release from the ER via the ryanodine receptor has also been shown to increase Ab production (Querfurth et al., 1997) . Taken together, these results point to ER calcium regulation as being a critical determinant for the production of Ab, in addition to plasma membrane influx pathways such as with CALHM1. As these results were not dependent upon the presence of FAD-linked mutant presenilin, it suggests that calcium regulation may be relevant to the progression of SAD and that targeting such channels may offer a viable way to delay or prevent the onset of SAD.
Concluding Remarks
For the first time since the original calcium hypothesis of AD was proposed, we have functional and genetic data that push calcium to the crux for the sporadic version of the disease and highlight several potential new therapeutic targets for both the prevention and treatment of the disease. What is interesting is that the crucial risk factor for SAD, aging, also involves significant changes in calcium homeostasis (Toescu et al., 2004) , which could contribute to the initiation of the disease.
